Fresenius SE KGaA (Fresenius SE KGaA) Capital Expenditure : $-1,222.98 Mil (TTM As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Fresenius SE KGaA Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Fresenius SE KGaA's cash flow for capital expenditures for the three months ended in Dec. 2023 was $-192 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was $-1,222.98 Mil.

Fresenius SE KGaA Capital Expenditure Historical Data

The historical data trend for Fresenius SE KGaA's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Capital Expenditure Chart

Fresenius SE KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

Get a 7-Day Free Trial

-5,492.22

-3,802.92

-3,441.81

-1,263.77

-1,236.64

Fresenius SE KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Capital Expenditure	Get a 7-Day Free Trial															311.44	-466.81	-477.79	-86.45	-191.93

Fresenius SE KGaA Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1,222.98 Mil.

Fresenius SE KGaA (Fresenius SE KGaA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (OTCPK:FSNUY) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

FSNUF:USA FREN:Mexico FRE:Italy FREd:UK 0OO9:UK FRE:Germany FRE:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.fresenius.com

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Fresenius SE KGaA (Fresenius SE KGaA) Headlines

From GuruFocus

Fresenius SE KGaA Stock Is Believed To Be Modestly Undervalued

By GF Value GF Value • 04-01-2021

Tweedy Browne Fund's 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood • 05-04-2021

Tweedy Browne Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood • 06-01-2021

Top 1st-Quarter Trades of the Tweedy Browne Global Value Fund

By Margaret Moran Margaret Moran • 04-13-2021

Fresenius SE & Co. KGaA to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 13 November 2019

By PRNewswire PRNewswire • 11-07-2019

Tweedy Brown Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood • 05-04-2021

Fresenius SE KGaA Stock Is Estimated To Be Fairly Valued

By GF Value • 07-02-2021